Evidence map›Paper›PMID 38167298›Full record

ArticleNature communications2024

Increase in antioxidant capacity associated with the successful subclone of hypervirulent carbapenem-resistant Klebsiella pneumoniae ST11-KL64.

Ruobing Wang, Anru Zhang, Shijun Sun, Guankun Yin, Xingyu Wu, Qi Ding, Qi Wang, Fengning Chen, Shuyi Wang, Lucy van Dorp and 5 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
9.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Emergence ofVirulence · 2026
    Article
  6. Emergence of carbapenem-resistant putative hypervirulentEmerging microbes & infections · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Clinical risk factors and genomic characterization of carbapenem-resistantFrontiers in cellular and infection microbiology · 2026
    Article
  18. Article
  19. Article
  20. Genetic characterization of carbapenem-resistantFrontiers in cellular and infection microbiology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 2 countries.

Ruobing WangDepartment of Clinical Laboratory, Peking University People's Hospital, Beijing, People's Republic of China.ORCID 0000-0002-9921-7271
Anru ZhangDepartment of Clinical Laboratory, Peking University People's Hospital, Beijing, People's Republic of China.
Shijun SunDepartment of Clinical Laboratory, Peking University People's Hospital, Beijing, People's Republic of China.
Guankun YinDepartment of Clinical Laboratory, Peking University People's Hospital, Beijing, People's Republic of China.
Xingyu WuDepartment of Clinical Laboratory, Peking University People's Hospital, Beijing, People's Republic of China.
Qi DingDepartment of Clinical Laboratory, Peking University People's Hospital, Beijing, People's Republic of China.
Qi WangDepartment of Clinical Laboratory, Peking University People's Hospital, Beijing, People's Republic of China.
Fengning ChenDepartment of Clinical Laboratory, Peking University People's Hospital, Beijing, People's Republic of China.
Shuyi WangDepartment of Clinical Laboratory, Peking University People's Hospital, Beijing, People's Republic of China.
Lucy van DorpUCL Genetics Institute, Department of Genetics, Evolution & Environment, University College London, London, UK.ORCID 0000-0002-6211-2310
Yawei ZhangDepartment of Clinical Laboratory, Peking University People's Hospital, Beijing, People's Republic of China.
Longyang JinDepartment of Clinical Laboratory, Peking University People's Hospital, Beijing, People's Republic of China.
Xiaojuan WangDepartment of Clinical Laboratory, Peking University People's Hospital, Beijing, People's Republic of China.
Francois BallouxUCL Genetics Institute, Department of Genetics, Evolution & Environment, University College London, London, UK.ORCID 0000-0003-1978-7715
Hui WangDepartment of Clinical Laboratory, Peking University People's Hospital, Beijing, People's Republic of China. whuibj@163.com.ORCID 0000-0001-9220-0357
Peking University · CNUniversity College London · GB

Funding

Medical Research Council MR/P007597/1
6 · The paper itself

Abstract

The acquisition of exogenous mobile genetic material imposes an adaptive burden on bacteria, whereas the adaptational evolution of virulence plasmids upon entry into carbapenem-resistant Klebsiella pneumoniae (CRKP) and its impact remains unclear. To better understand the virulence in CRKP, we characterize virulence plasmids utilizing a large genomic data containing 1219 K. pneumoniae from our long-term surveillance and publicly accessible databases. Phylogenetic evaluation unveils associations between distinct virulence plasmids and serotypes. The sub-lineage ST11-KL64 CRKP acquires a pK2044-like virulence plasmid from ST23-KL1 hypervirulent K. pneumoniae, with a 2698 bp region deletion in all ST11-KL64. The deletion is observed to regulate methionine metabolism, enhance antioxidant capacity, and further improve survival of hypervirulent CRKP in macrophages. The pK2044-like virulence plasmid discards certain sequences to enhance survival of ST11-KL64, thereby conferring an evolutionary advantage. This work contributes to multifaceted understanding of virulence and provides insight into potential causes behind low fitness costs observed in bacteria.

Indexed as

AntioxidantsCarbapenem-Resistant EnterobacteriaceaeAcclimatizationAnti-Bacterial AgentsCarbapenemsKlebsiella pneumoniaePhylogenyAnti-Bacterial AgentsAntioxidantsCarbapenems

Identifiers

PMID38167298
PMCPMC10761919
OpenAlexW4390509723

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.